Submit Your Groundbreaking Research

Deadline: Tuesday, April 22, 2025, 2:00 PM* 

Submit your presentation of novel technology for consideration to be included in the New York Valves 2025 innovation program. The technology should be relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease. We encourage submission of technologies at different stages of development.  

Submissions will be evaluated by a group of external reviewers and graded analogously to the science and case submissions. The innovation program development committee strives to find appropriate placement in the program for as many eligible submissions as possible.  

Top presentations from the meeting will be considered for the opportunity to publish a paper in JACC: Interventions, highlighting the most innovative trends in the structural heart space.

Submission File  

One PowerPoint file of 10 to 15 slides 

Slide Requirements  

Must include all the following as they relate to your technology: 

• Unmet clinical need it fills or its intended field of use 
• Description of the technology and differentiation from existing technologies 
• IP position/landscape 
• Summary of preclinical and/or early human data (if relevant) 
• Regulatory pathway/strategy and strategy for commercialization (if relevant) 

Extended Deadline: Tuesday, April 15, 2025, 2:00 PM*

Submit your most challenging cases in valvular and structural heart disease. The best submissions will be selected for presentation. Top cases will be published in JACC: Case Reports.

Submission File 

PowerPoint file of about five to 10 slides

Image Size and Formats 

• Video: Less than 30 MB in any of these formats: mpeg, wmv, avi, mov, mpg, mp4
• Still Image: Maximum 10 MB in any of these formats: .png, .jpg files only

Deadline: Tuesday, April 22, 2025, 2:00 PM* 

Submit your late-breaking clinical science and first-in-human and early feasibility studies for presentation at New York Valves 2025. Submissions should be first-time presentations of any of the following:

• The primary endpoint or major secondary endpoint results of a randomized clinical trials or high-quality observational studies/registries
• Insightful meta-analysis that may have an impact on clinical practice
• Early human clinical experience with novel devices

Embargo Information: Accepted late-breaking clinical science presentations are subject to strict embargo before they are officially presented. Please ensure a preliminary version of the presentation slides, including results, are ready for submission by Monday, June 16th, 2025.

Text Requirements 

Include full trial summary and primary endpoint data.

Character Limit 

• 3,000, including spaces and characters in images and tables
• Each image reduces character limit by 600
• Table reduces character limit by 300

Image Size and Formats 

• Maximum 10 MB per image
• .png and .jpg file format only
• Each image reduces your character limit by 600

Table 

• One table maximum
• No more than 20 rows and 10 columns
• Table reduces character limit by 300

Extended Deadline: Tuesday, April 15, 2025, 2:00 PM*

Submit abstracts that address valvular disease, transcatheter valve interventions, LAAO, and/or other structural heart disease diagnostic modalities or therapies.

Entries must be original research but may include portions of abstracts and/or manuscripts presented elsewhere. Clinical studies, basic science investigations, and preclinical studies are equally encouraged.

Character Limit 

• 2,200, including spaces and characters in images and table
• Each image reduces character limit by 600
• Table reduces character limit by 300

Table 

• One table maximum
• No more than 10 rows and/or 6 columns
• Table reduces character limit by 300

Image Size and Formats 

• Maximum 10 MB per image
• .png and .jpg file format only
• Each image reduces character limit by 600.

A Message for Accepted Moderated Abstract Presenters 

We are excited to invite you to submit the final version of your work to Structural Heart: The Journal of the Heart Team. Accepted abstracts will be published in the Structural Heart Journal, and your paper will undergo an expedited review process. If accepted and time allows, your paper will be published simultaneously.

To reset your Call for Science password, please log in to https://callforscience.crf.org/#/access/signin/ and select the "Forgot Password" option.

Yes, entries must be original research but may include portions of abstracts and/or manuscripts presented elsewhere.

Unfortunately, we are unable to accept submissions after the final submission deadline has elapsed.

Yes, you can make changes to your submission at any time before the submission deadline.

To manage your submission please enter the submission site. You can add authors or update information within the authors' profiles by visiting your submission and selecting the "Authors" tab. To designate a new presenter or author, simply check the "presenter" box next to the respective name.

New York Valves is exclusively an in-person event, and virtual participation is not offered.